Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

NCT02830724 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

124

Enrollment

NIH

Sponsor class

Conditions

Pancreatic Cancer
Renal Cell Cancer
Breast Cancer
Melanoma
Ovarian Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Aldesleukin
BIOLOGICAL: Anti-hCD70 CAR transduced PBL

Sponsor

National Cancer Institute (NCI)